In this work, we evaluated the ability of in situ self-assembled Au-antimiR-155 NCs to inhibit miR-155 activity, and the concomitant impact on the expression and function of TLR3, a predicted miR-155 target, in cultured HCC cells. Here, TLR3 is linked to hepatocellular carcinoma.